At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives; Peripheral vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 28 Sep 1998 Discontinued-Preclinical for Hypertension in United Kingdom (Unknown route)
- 29 Mar 1995 No-Development-Reported for Hypertension in United Kingdom (Unknown route)